| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.3 | 0.08 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | -0.25 | 0.09 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.25 | 0.08 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.22 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.14 | 0.006 |
| mRNA | PD-0332991 | FIMM | pan-cancer | AAC | -0.13 | 0.4 |